224 related articles for article (PubMed ID: 9030133)
1. Chemotherapy of leprosy: progress since the Orlando Congress, and prospects for the future.
Ji B; Levy L; Grosset JH
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S80-8; discussion S88-90. PubMed ID: 9030133
[No Abstract] [Full Text] [Related]
2. Future trends in the treatment of leprosy.
Pattyn SR
Trop Geogr Med; 1994; 46(2):85-8. PubMed ID: 8079396
[No Abstract] [Full Text] [Related]
3. Prospects for chemotherapy of leprosy.
Ji B
Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
[No Abstract] [Full Text] [Related]
4. Needed research in chemotherapy of leprosy related to the individual patient.
Jacobson RR
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S16-20. PubMed ID: 9030119
[TBL] [Abstract][Full Text] [Related]
5. Priorities for the future and prospects for leprosy control.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185
[No Abstract] [Full Text] [Related]
6. Progress in leprosy elimination.
World Health Forum; 1998; 19(2):212-3. PubMed ID: 9652225
[No Abstract] [Full Text] [Related]
7. Consensus development statement on the chemotherapy of leprosy. American Leprosy Missions International and G. W. Long Hansen's Disease Center.
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):644-52. PubMed ID: 1299717
[No Abstract] [Full Text] [Related]
8. Success of the WHO multidrug therapy?
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):61-4. PubMed ID: 8079392
[No Abstract] [Full Text] [Related]
9. The need for new drugs in the treatment and control of leprosy.
Baker RJ
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):78-97. PubMed ID: 2181046
[No Abstract] [Full Text] [Related]
10. [How should leprosy be treated?].
Mahé A
Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
[No Abstract] [Full Text] [Related]
11. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
12. Long-term follow-up of ROM treated cases.
Alam K; Butlin CR; Pahan D; Kumar S; Chowdhury
Lepr Rev; 2007 Jun; 78(2):160. PubMed ID: 17824488
[No Abstract] [Full Text] [Related]
13. Remaining challenges towards the elimination of leprosy. Leprosy Elimination Project World Health Organization.
Leprosy Elimination Project, World Health Oranization
Indian J Lepr; 2000; 72(1):33-45. PubMed ID: 10935185
[No Abstract] [Full Text] [Related]
14. Personalised therapy vs. fixed duration therapy.
Salafia A
Lepr Rev; 1997 Dec; 68(4):375-8. PubMed ID: 9503875
[No Abstract] [Full Text] [Related]
15. The final push to eliminate leprosy.
Neira MP
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S7-9. PubMed ID: 11757179
[No Abstract] [Full Text] [Related]
16. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750
[No Abstract] [Full Text] [Related]
17. Leprosy elimination--urgent action required.
Sansarricq H
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):60-3. PubMed ID: 10407630
[No Abstract] [Full Text] [Related]
18. Relapse rates following leprosy multidrug therapy.
Suite M
West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
[TBL] [Abstract][Full Text] [Related]
19. Risk of relapse in leprosy after fixed-duration multidrug therapy.
Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
[TBL] [Abstract][Full Text] [Related]
20. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
World Health Organization
Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
